AboutSign In

Aducanumab

Product

Controversial anti-amyloid antibody for Alzheimer's withdrawn by Biogen in 2024 after commercial failure

2 stories

01
health29d ago

Experimental Drug Shows First-Ever Reduction in Tau Pathology and Cognitive Benefit in Early Alzheimer's Trial

10 min read
02
health57d ago

Study Concludes Anti-Amyloid Alzheimer's Drugs Have No Clinically Meaningful Effect

9 min read